A Day Up For Aeglea BioTherapeutics, Inc.
Thu, Jun 22, 2023 at 07:42 PM
Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ) jumped higher at $0.46, representing a gain of 328.7%. On Thu, Jun 22, 2023, AGLE:NASDAQ hit a New 2-Week High of $0.46. The stock appeared on our News Catalysts scanner on Thu, Jun 22, 2023 at 08:50 AM in the 'ACQUISITION' category. From Thu, Jun 08, 2023, the stock recorded 44.44% Up Days and 20.00% Green Days
The stock spiked on Thu, Jun 22, 2023 at $0.96 with a volume of 252M+.
About Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ)
Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer.
Top 10 Gainers:
- Steel Connect, Inc. (STCN:NASDAQ), 1006.82%
- Aeglea BioTherapeutics, Inc. (AGLE:NASDAQ), 328.67%
- ShiftPixy, Inc. (PIXY:NASDAQ), 51.52%
- VCI Global Limited (VCIG:NASDAQ), 34.88%
- Root Inc. (ROOT:NASDAQ), 34.1%
- Xcel Brands, Inc. (XELB:NASDAQ), 32.54%
- Trxade Group, Inc. (MEDS:NASDAQ), 32.5%
- Edgio Inc Com (EGIO:NASDAQ), 31.03%
- Vyant Bio Inc. (VYNT:NASDAQ), 27.78%
- Sify Technologies Limited (SIFY:NASDAQ), 27.27%